Clearwater Capital Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,482
| Closed | -$43.1K | – | 162 |
|
|
2024
Q1 | $43.1K | Sell |
11,482
-402
| -3% | -$1.51K | ﹤0.01% | 157 |
|
|
2023
Q4 | $117K | Hold |
11,884
| – | – | 0.01% | 152 |
|
|
2023
Q3 | $99.2K | Sell |
11,884
-620
| -5% | -$5.18K | 0.01% | 138 |
|
|
2023
Q2 | $166K | Hold |
12,504
| – | – | 0.02% | 142 |
|
|
2023
Q1 | $145K | Hold |
12,504
| – | – | 0.02% | 147 |
|
|
2022
Q4 | $102K | Sell |
12,504
-1,600
| -11% | -$13.1K | 0.01% | 154 |
|
|
2022
Q3 | $82K | Hold |
14,104
| – | – | 0.01% | 150 |
|
|
2022
Q2 | $62K | Buy |
14,104
+800
| +6% | +$3.52K | 0.01% | 146 |
|
|
2022
Q1 | $121K | Buy |
13,304
+2,910
| +28% | +$26.5K | 0.01% | 163 |
|
|
2021
Q4 | $213K | Buy |
10,394
+1,365
| +15% | +$28K | 0.02% | 159 |
|
|
2021
Q3 | $231K | Buy |
9,029
+1,237
| +16% | +$31.6K | 0.03% | 156 |
|
|
2021
Q2 | $272K | Buy |
7,792
+398
| +5% | +$13.9K | 0.03% | 145 |
|
|
2021
Q1 | $246K | Buy |
+7,394
| New | +$246K | 0.03% | 148 |
|